Table 3 APOE genotypes, atrial fibrillation and ECG abnormalities in the study population. Total number and percentages of total (N = 505).
APOE Genotype | Atrial fibrillation | No atrial fibrillation | VPB*or SVPB | No VPB or SVPB | Conduction disturbances | No conduction disturbances |
|---|---|---|---|---|---|---|
ε2/ε2 | 1(0.2) | 1(0.2) | 0(0) | 2(0.4) | 0(0) | 2(0.4) |
ε2/ε3 | 7(1.4) | 53(10.5) | 35(6.9) | 26(5.1) | 9(1.8) | 52(10.3) |
ε2/ε4 | 1(0.2) | 13(2.6) | 8(1.6) | 6(1.2) | 4(0.8) | 10(2.0) |
ε3/ε3 | 54(10.7) | 240(47.5) | 122(24.2) | 173(34.3) | 25(4.9) | 269(53.3) |
ε3/ε4 | 20(4.0) | 107(21.2) | 55(10.9) | 70(13.9) | 10(1.9) | 116(23.0) |
ε4/ε4 | 3(0.6) | 5(0.9) | 2(0.4) | 6(1.1) | 0(0) | 8(1.6) |
Total | 86(17.0) | 419(81.7) | 222(43.7) | 283(56.3) | 48(9.4) | 457(90.6) |
P | 0.06 | 0.1 | 0.1 |